Table 4 Antibiotic treatments for NTM-PD patients
From: Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study
Hospitalization with an NTM-PD ICD-10 code (N =5628 ) n (%) | Total | ||
|---|---|---|---|
Yes N = 4898 | No N = 730 | ||
Treatment | |||
Any antibiotics | 703 (14.4) | 730 (100) | 1433 (25.5) |
Clarithromycin + Ethambutol | 232 (33.0) | 275 (377) | 507 (34.4) |
Clarithromycin + Rifampin + Ethambutol | 159 (22.6) | 166 (22.7) | 325 (22.1) |
Clarithromycin + Rifampin | 31 (4.4) | 121 (16.6) | 152 (10.3) |
Clarithromycin | 137 (19.5) | – | 137 (9.3) |
Azithromycin + Ethambutol | 43 (6.1) | 28 (3.8) | 71 (4.8) |
Azithromycin + Rifampin | 4 (0.6) | 64 (8.8) | 68 (4.6) |
Moxifloxacin + Rifampin + Ethambutol | 23 (3.3) | 36 (4.9) | 59 (4.0) |
Azithromycin + Rifampin + Ethambutol | 18 (2.6) | 25 (3.4) | 43 (2.9) |
Moxifloxacin + Ethambutol | 17 (2.4) | – | 17 (1.2) |
Clarithromycin + Moxifloxacin + Ethambutol | 11 (1.6) | 4 (0.5) | 15 (1.0) |
Clarithromycin + Moxifloxacin | 7 (1.0) | – | 7 (0.5) |
Clarithromycin + Ethambutol + Amikacin | 5 (0.7) | 1 (0.1) | 6 (0.4) |
Clarithromycin + Amikacin | 4 (0.6) | 1 (0.1) | 5 (0.3) |
Clarithromycin + Moxifloxacin + Rifampin | 1 (0.1) | 3 (0.4) | 4 (0.3) |
Moxifloxacin + Ethambutol + Amikacin | 2 (0.3) | 1 (0.1) | 3 (0.2) |
Azithromycin + Amikacin | 1 (0.1) | 1 (0.1) | 2 (0.1) |
Azithromycin + Rifampin + Ethambutol + Amikacin | 1 (0.1) | 1 (0.1) | 2 (0.1) |
Clarithromycin + Ethambutol + Rifabutin | 1 (0.1) | 1 (0.1) | 2 (0.1) |
Clarithromycin + Rifampin + Ethambutol + Amikacin | 2 (0.3) | – | 2 (0.1) |
Azithromycin + Amikacin + Ethambutol | – | 1 (0.1) | 1 (0.1) |
Clarithromycin + Azithromycin + Rifampin + Ethambutol | 1 (0.1) | – | 1 (0.1) |
Clarithromycin + Rifampin + Ethambutol + Rifabutin | – | 1 (0.1) | 1 (0.1) |
Moxifloxacin + Amikacin | 1 (0.1) | – | 1 (0.1) |
Moxifloxacin + Azithromycin | 1 (0.1) | – | 1 (0.1) |
Moxifloxacin + Rifabutin | 1 (0.1) | – | 1 (0.1) |